Global Parents for Eczema Research (GPER), one of LiVDerm’s partners in multiple educational initiatives to improve patient-clinician relations, recently partnered with several leading dermatologists and researchers to analyze the values and preferences of patients and their caregivers when treating atopic dermatitis (AD).
The results of this systemic review, recently published in JAMA Dermatology, revealed six key themes that may help inform optimal clinical care, practice guidelines, and future research.
The review identified 62 eligible studies for inclusion, which totaled 19,442 participants. Data demonstrated that patients and caregivers:
- Preferred to start treatment with non-medical, natural methods, opting to then step up any therapy with increasing AD severity.
- Preferred to use odorless treatments that are not visible and have minimal effect on their daily life.
- Favored treatments that relieved itching and burning.
- Wanted to make use of topical corticosteroids sparingly.
- Were concerned over the potential adverse effects of treatment.
- Valued a strong patient-clinician relationship.
GPER is proud and honored to have partnered with this large team on this systemic review.
